|

EVOLVE104 Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1: 1

Top Sponsors

  • EvolveImmune United, Inc1

Indications

  • Urethral Squamous Cell Carcinoma1
  • Vaginal Squamous Cell Carcinoma1
  • Cervical Squamous Cell Carcinoma1
  • Vulvar Squamous Cell Carcinoma1
  • Anal Squamous Cell Carcinoma1

Los Angeles, California1 trial

A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial and Squamous Cell Carcinomas

USC/Norris Comprehensive Cancer Center

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.